Page 3 - P4403.59-V62 numark mag april 5
P. 3
Newly formulated
range of Ramipril
Oral Solution...
NOW IN
THREE
STRENGTHS
Patients with swallowing
difficulties may find a liquid
formulation easier to swallow
than tablets or capsules
*Switch from tablets and unlicensed medicines.
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor and is utilised for multiple Scan the Scan the
indications, including hypertension and prevention of heart failure progression following
a myocardial infarction (MI). 1-3 QR code to access QR code to access
the Rosemont Prescribing
References: 1. Ramipril 2.5mg/5ml Oral Solution SmPC. Rosemont Pharmaceuticals Ltd. website Information
2024. 2. Ramipril 5mg/5ml Oral Solution SmPC. Rosemont Pharmaceuticals Ltd. 2024.
3. Ramipril 10mg/5ml Oral Solution SmPC. Rosemont Pharmaceuticals Ltd. 2024.
Adverse events should be reported. Reporting forms and information
can be found at https://yellowcard.mhra.gov.uk. Adverse events
should also be reported to Rosemont at 0113 244 1400 or
pharmacovigilance@rosemontpharma.com
ROS000132-020 DOP: December 2024
P4403.59-V62 numark mag april.indd 3 11/03/2025 10:50:57
11/03/2025 10:50:57
P4403.59-V62 numark mag april.indd 3
03/01/2025 08:42
03725-01 Ramipril_Ad_A4_297x210_AW.indd 1
03725-01 Ramipril_Ad_A4_297x210_AW.indd 1 03/01/2025 08:42
